Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Altamira Therapeutics Ltd CYTO

Healthcare
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYTO)

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

GlobeNewswire 9 days ago

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

GlobeNewswire April 4, 2024

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

GlobeNewswire March 25, 2024

Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

GlobeNewswire February 7, 2024

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

GlobeNewswire January 24, 2024

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

GlobeNewswire January 8, 2024

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire December 29, 2023

Altamira Therapeutics Provides Investor and Business Update

GlobeNewswire December 11, 2023

Altamira Therapeutics to Host Investor & Business Update Call on December 11th

GlobeNewswire December 5, 2023
View More News ››

Opinion & Analysis (NDAQ:CYTO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CYTO)

CYTO......called this almost to the T

Now hear this !!!!!!! FWIW.....I see a pump during AH......It will be quick....so make sure you bid whack JMHO Me...no position And...
Iseneschal - March 25, 2024

RE:RE:RE:CYTO....in PB mode

Not 2 bags ; ) 2 cents off the Low of Day Not a bad call ...all considering ; ) I get zero likes for being right again.....u sure r a...
Iseneschal - March 25, 2024

CYTO..... N.L.O.D...now $2.16

Sheesh
Iseneschal - March 25, 2024

RE:RE:CYTO.....This is what I'm thinking now...FWIW ; )

And like I said....don't expect too much ; ) Now looking at "the big picture".......almost 60 million shares have traded...
Iseneschal - March 25, 2024

RE:CYTO.....This is what I'm thinking now...FWIW ; )

Pop goes the weasel !
Iseneschal - March 25, 2024

CYTO.....This is what I'm thinking now...FWIW ; )

I would have to think that there will be 1 more ramp up....If u have a Gambling addiction...pick a spot sub $2.20....watch for some "...
Iseneschal - March 25, 2024
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »